Parkinson’s Disease

Research Article

Impact of Mézières Rehabilitative Method in Patients with Parkinson’s Disease: A Randomized Controlled Trial

Table 5

Scales and clinical evaluation: comparison for the control group at 3 evaluation times.


Scales and clinical evaluations for the control group	T0		T1		T2				Effect
Scales and clinical evaluations for the control group	Median	IQR	Median	IQR	Median	IQR			Effect

VAS (cm)	3.0	3.5	2.5	4.0	3.0	4.0	0.226	—

SF36-PF	75.0	45.0	75.0	35.0	85.0	45.0	0.108	—
SF36-RP	50.0	75.0	100.0	50.00	100.0	45.0	0.054	—
SF-36 BP	61.0	20.0	61.0	31.00	61.0	50.0	0.497	—
SF-36 GH	42.0	13.0	47.0	25.00	45.0	33.0	0.627	—
SF-36 VT	50.0	10.0	50.0	15.00	50.0	23.0	0.412	—
SF-36 SF	75.0	38.0	75.0	25.00	87.5	23.3	0.575	—
SF-36 RE	66.7	66.7	66.7	34.00	100.0	50.0	0.430	—
SF-36 MH	68.0	16.0	64.0	28.00	60.0	28.0

BBS	48.00	7.0	50.0	8.00	50.0	5.0	0.360	—

Trunk flexion test (cm)	11.00	10.0	10.0	10.00	10.0	10.0	0.012

FGA	14.00	6.0	11.0	6.00	11.0		<0.001

MPAS	37.00	13.0	40.0	10.00	40.0	10.0	<0.001

SMWT (min)	480.00	120.0	500.0	145.00	500.0	130.0	0.005	1	0.26

UPDRS Part I	10.00	8.0	7.0	7.00	8.0	8.0	0.262	—
UPDRS Part II	9.00	9.0	7.0	6.00	6.0	8.0	0.050	—
UPDRS Part III	14.00	10.0	11.0	8.00	13.0	10.0	0.064	—
UPDRS Part IV	4.00	6.0	2.0	5.00	0.9	5.0	<0.001
UPDRS Total	44.00	0.0	49.0	0.00	37.0	0.0	0.015	2

Group B: control group; IQR: interquartile range; SF-36: Short Form 36 Health Survey; PF: physical functioning; PR: physical role functioning; BD: bodily pain; GH: general health perceptions; VT: vitality; SF: social role functioning; RE: emotional role functioning; MH: mental health; VAS: Visual Analog Scale; BBS: Berg Balance Scale; FGA: Functional Gait Assessment; MPAS: Modified Parkinson’s Activity Scale; SMWT: six-minute walking test; UPDRS: Unified Parkinson’s Disease Rating Scale. value obtained by Friedman test. Significant comparisons obtained by Wilcoxon test with Bonferroni correction (0.017 is the critical level of significance of Bonferroni correction, i.e., 0.05/3: versus ; versus ; versus ; not significant comparisons). Effect size for the post hoc comparison. Bold font indicates statistical significance.